Product NDC: | 16729-179 |
Proprietary Name: | AMLODIPINE BESYLATE |
Non Proprietary Name: | Amlodipine besylate |
Active Ingredient(s): | 2.5 mg/1 & nbsp; Amlodipine besylate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16729-179 |
Labeler Name: | Accord Healthcare Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA202553 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130701 |
Package NDC: | 16729-179-43 |
Package Description: | 100 TABLET in 1 BOX, UNIT-DOSE (16729-179-43) |
NDC Code | 16729-179-43 |
Proprietary Name | AMLODIPINE BESYLATE |
Package Description | 100 TABLET in 1 BOX, UNIT-DOSE (16729-179-43) |
Product NDC | 16729-179 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Amlodipine besylate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20130701 |
Marketing Category Name | ANDA |
Labeler Name | Accord Healthcare Inc. |
Substance Name | AMLODIPINE BESYLATE |
Strength Number | 2.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |